Translating synchrotron microbeam radiation therapy into a clinical reality for cancer patients

将同步加速器微束放射治疗转化为癌症患者的临床现实

• 批准号: nhmrc : 1036174
• 负责人: A/Pr Jeffrey Crosbie
• 金额: $ 22.53万
• 依托单位: RMIT University
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/translating-synchrotron-microbeam-cancer-patients/111001
• 关键词: Translating; synchrotron; microbeam; radiation; therapy

The aim of this project is to translate an experimental radiotherapy technique, known as microbeam radiotherapy, into a clinical reality for the benefit of cancer patients world-wide. I propose to achieve this aim by working at the European Synchrotron Radiation Facility (ESRF) in France. The ESRF is Europe’s most powerful synchrotron light source, where a multi-disciplinary team of scientists and physicians are collaborating to treat the first human cancer patients with synchrotron radiation.

该项目的目的是将一种名为微束放射治疗的实验性放射治疗技术转化为临床现实，造福世界各地的癌症患者。我建议通过在法国的欧洲同步辐射设施(ESRF)工作来实现这一目标。ESRF是欧洲最强大的同步辐射光源，一个由科学家和医生组成的多学科团队正在合作，用同步辐射治疗第一批人类癌症患者。